New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...
July 24, 2024 — Scientists have discovered that the serrated edges of Komodo dragons' teeth are tipped with iron. The study gives new insight into how Komodo dragons keep their teeth razor-sharp ...
Der Schweizer Aktienmarkt hat am Mittwoch im Vorfeld des mit Spannung erwarteten Zinsentscheids in den USA nachgegeben. Nach ...
Novartis AG (NYSE:NVS) released new data Wednesday from the ALITHIOS open-label extension study. Data show first-line ...
Die US-Gesundheitsbehörde FDA hat das Novartis-Medikament Kisqali für die Behandlung von Patientinnen mit einer bestimmten ...
BASF plant Umbau-Pläne für Agrarchemie und Beschichtungen.Google siegt vor EU-Gericht.Tupperware stellt US-Insolvenzantrag.
Novartis hat neue Daten zu seinem Medikament Kesimpta vorgelegt, das zur Behandlung von schubförmiger Multipler Sklerose (RMS ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
When Roche's Genentech gained approval for Ocrevus in 2017, the first-in- | On the same day that Roche gained an FDA approval ...
Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback